Turn Therapeutics Inc.

TTRX Nasdaq SEC CIK 2023016
Follow Turn Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$6.2M −227.2% vs same quarter last year
EPS, diluted −$0.21 −200% vs same quarter last year
Operating cash flow −$1.5M −163.2% vs same quarter last year
Operating income −$2M −3.7% vs same quarter last year
Net income by quarter
−$323.1K
−$328.5K
−$1.2M
−$1.9M
$279.1K
−$971K
−$5.8M
−$6.2M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing